Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 8 articles:
HTML format
Text format



Single Articles


    August 2018
  1. ROTHWELL PM, Cook NR, Gaziano JM, Price JF, et al
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.
    PubMed     Text format     Abstract available


    July 2018
  2. GEORGE AT, Aggarwal S, Dharmavaram S, Menon A, et al
    Regional variations in UK colorectal cancer screening and mortality.
    Lancet. 2018;392:277-278.
    PubMed     Text format    


    June 2018
  3. TEKKIS P, Tait D, Cunningham D, Brown G, et al
    Is organ preservation in rectal cancer ready for prime time?
    Lancet. 2018;391:2480-2482.
    PubMed     Text format    


  4. VAN DER VALK MJM, Hilling DE, Bastiaannet E, Meershoek-Klein Kranenbarg E, et al
    Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study.
    Lancet. 2018;391:2537-2545.
    PubMed     Text format     Abstract available


    May 2018
  5. PAGES F, Mlecnik B, Marliot F, Bindea G, et al
    International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.
    Lancet. 2018 May 10. pii: S0140-6736(18)30789.
    PubMed     Text format     Abstract available


  6. OGINO S, Giannakis M
    Immunoscore for (colorectal) cancer precision medicine.
    Lancet. 2018 May 10. pii: S0140-6736(18)30953.
    PubMed     Text format    


    January 2018
  7. JIA H, Guan Y, Zhu J
    GRECCAR2 trial: details worthy of more attention.
    Lancet. 2018;391:122.
    PubMed     Text format    


  8. RULLIER E, Vendrely V, Denost Q, Asselineau J, et al
    GRECCAR2 trial: details worthy of more attention - Authors' reply.
    Lancet. 2018;391:122-123.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: